{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:44:39Z","timestamp":1789764279467,"version":"4.0.1"},"reference-count":17,"publisher":"Baishideng Publishing Group Inc.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJP"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5498\/wjp.v3.i3.62","type":"journal-article","created":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T02:04:45Z","timestamp":1410919485000},"page":"62","source":"Crossref","is-referenced-by-count":20,"title":["Acetyl Cholinesterase inhibitors in cognitive impairment in Huntington\u2019s disease: A brief review"],"prefix":"10.5498","volume":"3","author":[{"given":"Joe John","family":"Vattakatuchery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Lanska DJ. George Huntington (1850-1916) and hereditary chorea. J Hist Neurosci 2000;9:76-89.","DOI":"10.1076\/0964-704X(200004)9:1;1-2;FT076"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25075"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70245-3"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/ng0893-393"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(00)71170-4"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21971"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-381328-2.00013-4"},{"key":"ref8","unstructured":"Montoya A, Price BH, Menear M, Lepage M. Brain imaging and cognitive dysfunctions in Huntington&rsquo;s disease. J Psychiatry Neurosci 2006;31:21-29."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/103.1.179"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/BF00862983"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Fernandez HH, Friedman JH, Grace J, Beason-Hazen S. Donepezil for Huntington&rsquo;s disease. Mov Disord 2000;15:173-176.","DOI":"10.1002\/1531-8257(200001)15:1<173::AID-MDS1032>3.0.CO;2-T"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2002.00447_4.x"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Petrikis P, Andreou C, Piachas A, Bozikas VP, Karavatos A. Treatment of Huntington&rsquo;s disease with galantamine. Int Clin Psychopharmacol 2004;19:49-50.","DOI":"10.1097\/00004850-200401000-00010"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20235"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000238106.10423.00"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnf.0000240945.44370.f0"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006456.p"}],"container-title":["World Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/2220-3206\/full\/v3\/i3\/62.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T02:48:16Z","timestamp":1565837296000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/2220-3206\/full\/v3\/i3\/62.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5498\/wjp.v3.i3.62","relation":{},"ISSN":["2220-3206"],"issn-type":[{"value":"2220-3206","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}